跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
ARIPIPRAZOL PENSA 5 MG COMPRIMIDOS EFG - CIMA-AEMPS Drug Approval Details
Approvals
/
CIMA-AEMPS
/
ARIPIPRAZOL PENSA 5 MG COMPRIMIDOS EFG
Approved
STANDARD
ARIPIPRAZOL PENSA 5 MG COMPRIMIDOS EFG
Towa Pharmaceutical S.A.
🇪🇸 Spanish Agency of Medicines and Medical Devices
Approval Date
Nov 11, 2021
Approval ID
0ad75bd083147f42
Company
Towa Pharmaceutical S.A.
Type
Standard
Approval Details
Approval Id
0ad75bd083147f42
Drug Cima Aemps Name
ARIPIPRAZOL PENSA 5 MG COMPRIMIDOS EFG
Register Number
86374
Holder Company Name
Towa Pharmaceutical S.A.
Marketing Company Name
Towa Pharmaceutical S.A.
Authorization Date
2021-11-11
Dosage Form
COMPRIMIDO
Dose
5 mg
Route Of Administration
VÍA ORAL
Prescription Type
Medicamento Sujeto A Prescripción Médica
Commercialized
Yes
Company Name
Towa Pharmaceutical S.A.
Active Ingredients
ARIPIPRAZOL
5 mg
Approved
Quick Info
Agency
CIMA-AEMPS
Country
🇪🇸
Approval Date
Nov 11, 2021
Approval ID
0ad75bd083147f42
Type
Standard
Back to CIMA-AEMPS Approvals